介入治疗对原发性肝癌病人血清sIL-2R水平的影响

INFLUENCES OF INVENTIONAL TREATMENT FOR PATIENTS WITH PHC ON sIL-2R

目的：探讨介入治疗对原发性肝癌病人的血清可溶性白介素２受体（ｓＩＬ－２Ｒ）的影响。方法：经皮股动脉穿刺选择性肝动脉化疗栓塞；用ＥＬＩＳＡ法检测肝癌病人的ｓＩＬ－２Ｒ水平。结果：肝癌病人的血清ｓＩＬ－２Ｒ水平与肝癌体积有关；行介入治疗后约１周内ｓＩＬ－２Ｒ无变化，２～３周后明显下降。结论：介入治疗肝癌是有效的；测定ＰＨＣ患者的血清ｓＩＬ－２Ｒ不仅能了解机体免疫功能状态。

Objective: To observe the role of inventional treatment affecting the level of sIL 2R in patients with PHC Methods: The level of sIL 2R were tested by ELISA before and after the patients accepted inventional treatment Results: The serum sIL 2R in patients with PHC was correlated with the size of neoplasm, and it did not change after inventional treatment for a week, however, it decreased markedly after inventional treatment for 2 to 3 weeks Conclusions:Inventional treatment is effective to PHC By measuring the serum sIL 2R level of PHC, we not only understand the immune function of the patients, but also help to judge the therapeutic effect and assess the prognosis